Search for Clinical Trial Results
Merkel Cell Carcinoma - 28 Studies Found
Status | Study |
Completed |
Study Name: Oblimersen in Treating Patients With Merkel Cell Carcinoma Condition:
|
Completed |
Study Name: BB-10901 in Treating Patients With Relapsed or Refractory Solid Tumors Condition:
|
Not yet recruiting |
Study Name: Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers Condition:
|
Completed |
Study Name: Irinotecan in Treating Patients With Advanced Neuroendocrine Tumors Condition:
|
RECRUITING |
Study Name: Phase II Study of Peptide Receptor Radionuclide Therapy in Combination With Immunotherapy for Patients With Merkel Cell Cancer Condition: Merkel Cell Carcinoma Date: 2024-05-19 Interventions: Pembrolizumab 400mg IV |
RECRUITING |
Study Name: Neoadjuvant PD-1 Blockade in Resectable Merkel Cell Carcinoma Condition: Merkel Cell Carcinoma Date: 2024-05-19 Interventions: 400mg IV |
RECRUITING |
Study Name: Triple Immune Checkpoint Inhibition for Advanced or Metastatic PD-(L)1 Refractory Merkel Cell Carcinoma Condition: Unresectable Clinical Stage III Merkel Cell Carcinoma AJCC v8 Date: 2024-05-19 Interventions: Undergo tumor biopsy |